Mazodier et al. reported that in patients with MAS, free IL-18 concentration significantly correlated with both clinical activity and markers of Th1 lymphocyte or macrophage activation, such as elevated concentrations of IFNγ and soluble IL-2 and TNFα receptor concentrations [78]. The gene discussed is IL18; the disease is macrophage activation syndrome.